This federal contract award, valued at $37,456.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dupixent 300 mg/2 ml pen (2 ml), a specialty medication, with a completion date of December 5, 2024. The contract type is Delivery Order with a Firm Fixed Price pricing structure. There is no set-aside designation mentioned in the award information. Amerisourcebergen Drug Corp, the prime contractor, is a for-profit organization registered in the System for Award Management (SAM.gov) through June 2025. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/5/25, 9:58 AM